RA Capital

venture capital money financing pay idea startup biotech

AltruBio raises $225M for midphase ulcerative colitis program

AltruBio has roared back after another pivot in its twisty history, securing $225 million to test an immune checkpoint enhancer in ulcerative colitis.

Nick Paul Taylor May 21, 2024 8:00am

BMS-backed TORL grabs $158M to march army of ADCs through clinic

Apr 10, 2024 9:35am

Graphic images of red and white pill capsules lined up diagonally in front of a yellow background

Diagonal launches with $128M to grow agonist antibody platform

Apr 3, 2024 6:00am

Eliem cuts in on Tango, proposing acquisition after review

Mar 19, 2024 10:57am

Photo of a sheep leaping forward seemingly off a rock elevated above other sheep

Boundless Bio bumps IPO market back to life

Mar 6, 2024 5:20pm

VC investment in biopharma dropped nearly $7B in 2023: PitchBook

Mar 5, 2024 5:00am